- Programm
- Horizon 2020 & sub-programmes
- Laufzeit
- 78 Monate (March 2016 – August 2022)
- Projektförderung
- ≈ €28 million
- Projektpartner
- 21
- Projektwebsite
- Projektwebsite besuchen
Worum es geht
PERISCOPE aims to accelerate the development of improved vaccines against Bordetella pertussis (whooping cough) and/or vaccination strategies that will be used to control B. pertussis in humans. PERISCOPE will develop novel functional antibody and cellular assays and employs cutting-edge methods to characterise innate immune responses and cell-mediated systemic and mucosal immunity.
Koordination
Dimitri Diavatopoulos
Radboud University Medical Center
Explore THE COURT
Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.
THE COURT betreten